Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.

Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H, Ohtani H.

Cancer Res. 2001 Jul 1;61(13):5132-6.

2.

[Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].

Benchetrit F, Gazagne A, Adotevi O, Haicheur N, Godard B, Badoual C, Fridman WH, Tartour E.

Bull Cancer. 2003 Aug-Sep;90(8-9):677-85. Review. French.

PMID:
14609756
3.

[Paraneoplastic nephropathy associated with adult renal carcinoma (immunologic and clinicopathologic study)].

Kiss B, Magyarlaki T, Buzogány I, Fazekas A, Sükösd F, Nagy J.

Orv Hetil. 1999 Jan 10;140(2):75-80. Review. Hungarian.

PMID:
9949663
4.

CD20+ B cells: the other tumor-infiltrating lymphocytes.

Nelson BH.

J Immunol. 2010 Nov 1;185(9):4977-82. doi: 10.4049/jimmunol.1001323. Review.

6.
7.

Tumor-infiltrating cells and their possible prognostic significance.

Pastrnák A, Jansa P.

Acta Univ Palacki Olomuc Fac Med. 1989;124:7-71. Review.

PMID:
2530850
8.

Prognostic and predictive impact of intra- and peritumoral immune infiltrates.

Fridman WH, Galon J, Pagès F, Tartour E, Sautès-Fridman C, Kroemer G.

Cancer Res. 2011 Sep 1;71(17):5601-5. doi: 10.1158/0008-5472.CAN-11-1316. Epub 2011 Aug 16. Review.

9.

Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity.

Jochems C, Schlom J.

Exp Biol Med (Maywood). 2011 May 1;236(5):567-79. doi: 10.1258/ebm.2011.011007. Epub 2011 Apr 12. Review.

10.

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P.

Blood. 2001 Jan 15;97(2):339-45. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk